Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Dec 15;172(12):1487-90.
doi: 10.1164/rccm.200504-613PP. Epub 2005 Sep 8.

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis

Svetlana Gelperina  1 , Kevin Kisich, Michael D Iseman, Leonid Heifets
Affiliations
Review

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis

Svetlana Gelperina et al. Am J Respir Crit Care Med. .

Abstract

Nanoparticle-based drug delivery systems have considerable potential for treatment of tuberculosis (TB). The important technological advantages of nanoparticles used as drug carriers are high stability, high carrier capacity, feasibility of incorporation of both hydrophilic and hydrophobic substances, and feasibility of variable routes of administration, including oral application and inhalation. Nanoparticles can also be designed to allow controlled (sustained) drug release from the matrix. These properties of nanoparticles enable improvement of drug bioavailability and reduction of the dosing frequency, and may resolve the problem of nonadherence to prescribed therapy, which is one of the major obstacles in the control of TB epidemics. This article highlights some of the issues of nanotechnology relevant to the anti-TB drugs.

PubMed Disclaimer

References

    1. Salem II, Flasher DL, Duzgunes N. Liposome-encapsulated antibiotics. Methods Enzymol 2005;391:261–291. - PubMed
    1. Khuller GK, Kapur M, Sharma S. Liposome technology for drug delivery against mycobacterial infections. Curr Pharm Des 2004;10:3263–3274. - PubMed
    1. Kreuter J. Nanoparticles as drug delivery system. In: Nalwa HS, editor. Encyclopedia of nanoscience and nanotechnology. Vol. 7. New York: American Scientific Publishers; 2004. pp. 161–180.
    1. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004;21:387–422. - PubMed
    1. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003;55:519–548. - PubMed

Publication types

Substances